USE NOVEL LIGHT SENSITIVE CHANNEL PROTEIN VR 1.0 IN PREPARATION OF RETINAL PHOTORECEPTOR CELL DEGENERATIVE DISEASE DRUG | Patent Publication Number 20230348552

US 20230348552 A1
Patent Number-
Application Number18120007
Filled DateMar 10, 2023
Priority DateJun 9, 2022
Publication DateNov 2, 2023
Original AssigneeZhongmou Medical Technology Wuhan Co. Ltd.
Current AssigneeZhongmou Therapeutics Co. Ltd.
Inventor/ApplicantsYin SHEN
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.